Drugs / Biologically active human fecal material
Biologically active human fecal material
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02460705 | Jun 2015 → Dec 2016 | inflammatory bowel disease | University of California, San Francisco | Completed | No outcome recorded |
| Phase 0 | NCT02428361 | May 2015 → Apr 2018 | pouchitis | Najwa Elnachef | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biologically active human fecal material | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02428361 ↗ |
| Modality | Other / unclassified | “Fecal microbiota transplant” NCT02428361 ↗ |
| Route | Other | “will administer 250 mL of the fecal suspension in aliquots of 50-60 mL through the endoscope” NCT02428361 ↗ |